Hearing screening in neonates receiving vancomycin in the neonatal intensive care units / Waad Mohamed Alsayed Alshazly ; Supervised Mona Mohsen Alattar , Dalia Ahmed Khairy Abdellatif , Amira Maged Alshennawy

By:

Waad Mohamed Alsayed Alshazly

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Waad Mohamed Alsayed Alshazly , 2014Description: 99 P. : charts , facsimiles ; 25cmOther title:

المسح السمعى للاطفال حديثى الولاده الذين يتلقون عقار االفانكوميسين برعاية حديثى الولاده [Added title page title]

Subject(s):

Online resources:

Click here to access online

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics Summary: Hearing impairment is the most common congenital defect, acquired hearing loss may develop as side effect of using ototoxic drugs. To assess the effect of vancomycin on hearing of newborns admitted to NICU. This case control study included 100 neonate (50 received vancomycin) and ( 50 didn{u2019}t receive vancomycin). History, investigations done during admission and OAE tests were done. OAE tests were normal in both groups indicating vancomycin not ototoxic. Using vancomycin is not ototoxic to neaonates when used in standard dose and duration

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.28.M.Sc.2014.Wa.H (Browse shelf(Opens below))		Not for loan	01010110064250000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.28.M.Sc.2014.Wa.H (Browse shelf(Opens below))	64250.CD	Not for loan	01020110064250000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.28.M.Sc.2014.Ta.S Serum Leptin as an indicator for severity of pneumonia /	Cai01.11.28.M.Sc.2014.Ta.S Serum Leptin as an indicator for severity of pneumonia /	Cai01.11.28.M.Sc.2014.Wa.H Hearing screening in neonates receiving vancomycin in the neonatal intensive care units /	Cai01.11.28.M.Sc.2014.Wa.H Hearing screening in neonates receiving vancomycin in the neonatal intensive care units /	Cai01.11.28.M.Sc.2014.Wa.R The role of sample collection timing on interleukin 6 level in early onset sepsis /	Cai01.11.28.M.Sc.2014.Wa.R The role of sample collection timing on interleukin 6 level in early onset sepsis /	Cai01.11.28.M.Sc.2014.Wa.S A study of the prevalence and risk factors of hepatobiliary dysfunction in Egyptian children with chronic hemolytic anemia /	Next

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics

Hearing impairment is the most common congenital defect, acquired hearing loss may develop as side effect of using ototoxic drugs. To assess the effect of vancomycin on hearing of newborns admitted to NICU. This case control study included 100 neonate (50 received vancomycin) and ( 50 didn{u2019}t receive vancomycin). History, investigations done during admission and OAE tests were done. OAE tests were normal in both groups indicating vancomycin not ototoxic. Using vancomycin is not ototoxic to neaonates when used in standard dose and duration

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer